DFB Healthcare Acquisitions Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Feb 16, 2018 |
| CEO | Richard Barasch |
| Left Lead | Goldman Sachs |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | AdaptHealth |
| Deal Announced | Jul 8, 2019 |
| Deal Size, $M | $1,041.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Nov 7, 2019 |
| Amendment Vote | TBD |
| Closing Date | Nov 8, 2019 |
Formerly DFBH
AHCO
AHCOW
| Price | $9.72 |
|---|---|
| Last closing price | $9.74 |
| H/L, today | $9.55 / $9.80 |
| H/L, 52-week | $6.92 / $23.09 |
| Volume, today | 683,111 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on DFB Healthcare Acquisitions Corp.:
- Structure and cap table
- 6 directors & officers
- 28 filings and events
- 3 underwriters
- 5 deal advisors
- 4 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Richard Barasch | 64 | President, Chief Executive Officer and Chairman |
| Christopher Wolfe | 38 | Chief Financial Officer |
| Steven Hochberg | 56 | Director |
| Dr. Mohit Kaushal | 39 | Director |
| Dr. Gregory Sorensen | 55 | Director |
| Dr. Susan Weaver | 56 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Goldman Sachs | Joint BR | 12,500,000 | units |
| Deutsche Bank | Joint BR | 8,750,000 | |
| SVB Securities | 3,750,000 | ||
| 25,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.